Search Results - Gy Waldron

1

Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma.

by Justin P Williams, Inki Kim, Emma Ito, Wei Shi, Shijun Yue, Lillian L Siu, John Waldron, Brian O'Sullivan, Kenneth W Yip, Fei-Fei Liu
Published 2014-01-01
“... (10-500 nM), both with and without IR (2-4 Gy). The FaDu xenograft model was utilized for tumor growth...”

Get full text

Article
2

$Durable therapeutic gain despite competing mortality in long-term follow-up of a randomized hyperfractionated radiotherapy trial for locally advanced head and neck cancer$

Durable therapeutic gain despite competing mortality in long-term follow-up of a randomized hyperfractionated radiotherapy trial for locally advanced head and neck cancer

by Brian O'Sullivan, Shao Hui Huang, Thomas Keane, Wei Xu, Jie Su, John Waldron, Patrick Gullane, Fei-Fei Liu, Padraig Warde, David Payne, Li Tong, Bernard Cummings
Published 2020-03-01
“...: From 1988 to 1995, 331 cases were randomized to either hyperfractionated (HF) (58 Gy/40 fractions...”

Get full text

Article